Top European Service Provider GATC Biotech Ramps Up Its Fleet of Next-Gen Sequencers with Second Genome Sequencer FLX System from Roche

BRANFORD, Conn.--(BUSINESS WIRE)--454 Life Sciences, a centre of excellence of Roche Applied Science, today announced that GATC Biotech, one of Europe’s leading sequencing service providers, has acquired a second Genome Sequencer FLX System. GATC Biotech's decision to add an additional Genome Sequencer FLX System to its service offering was based both on soaring demand for ultra high-throughput sequencing services as well as the goal to set new industry standards in terms of turn around time, and quality of results.